A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Phase 1 Completed 21 enrolled Vertex Pharmaceuticals Incorporated

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to evaluate the relative bioavailability (BA) and the effect of food on the pharmacokinetics (PK), and the safety and tolerability of VX-147 test tablet formulation.

Timeline

Start: 2023-07-19
Primary completion: 2023-09-02
Completion: 2023-09-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Inaxaplin	Small molecule	—	Oral

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Summary

Timeline

Drugs

Indications